NCT06862531
A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.
Phase: N/A
Role: Lead Sponsor
Start: Sep 25, 2020
Completion: Nov 17, 2020